RxDoctor Payments Data

Dana Hunley

Family · Hendersonville, TNNPI 1215317383

Payments from drug & device makers

$5,673in general payments, 2019–2025

Across 296 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • AbbVie$924
  • Collegium Pharmaceutical, Inc.$881
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$604
  • Pfizer$297
  • Scilex Pharmaceuticals Inc.$195
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$5,673100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,673 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$94,300
Medicare patients
445
Services billed
1,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate99$64,344
Nucynta ErTapentadol Hcl41$47,180
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,032$45,768
RelistorMethylnaltrexone Bromide15$43,211
BelbucaBuprenorphine Hcl42$38,526
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,068$38,507
OxycontinOxycodone Hcl27$27,067
LinzessLinaclotide21$12,645
Hysingla ErHydrocodone Bitartrate11$10,656
Fentanyl45$10,277
Buprenorphine36$8,777
Pregabalin271$8,316
Gabapentin509$8,249
Diclofenac Sodium46$7,781
Morphine Sulfate ErMorphine Sulfate286$6,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca$881$150,051182 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$604$43,21115 claims
AbbVieLinzess$924$12,64521 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$19$9,37965 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Hendersonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →